Copyright 2008 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
We are concerned that the article by Chiang and colleagues1 and accompanying editorial by Phelps2 could lead to mismanagement and inappropriate care for infants with retinopathy of prematurity (ROP). Based on their study, Chiang and colleagues concluded: “Interexpert agreement of plus disease diagnosis is imperfect. This may have important implications for clinical ROP management, continued refinement of the international ROP classification system, development of computer-based diagnostic algorithms, and implementation of ROP telemedicine systems.”1 (p875) These comments imply more than the words stipulate. We believe that many readers will interpret this conclusion to mean that the diagnosis of plus disease is so faulty that it is useless in the management of ROP.
The conclusions drawn by Chiang et al are inappropriate for the design of their study. Selected wide-angle photographs were sent to experts for their review. Noticing considerable disagreement in the diagnosis of plus disease among these experts, Chiang et al made far-reaching conclusions about the inability of experts to agree on the proper diagnosis of plus disease. Such a conclusion would require masked paired examinations of the same infant rather than a review of wide-angle photographs.
Additional flaws in the study design are apparent. The camera used in the experiment offers a minified view compared with the standard reference photograph of plus disease.3 The camera itself places weight on the eye and can change the appearance of plus disease or stage 3 ROP. Experts were shown photos that were devoid of any other anatomical information (eg, presence or absence of stage 3 disease). These additional factors are helpful during indirect ophthalmoscopy in real life. Pictures shown to experts were very ambiguous. Thus, Chiang et al probed interexpert agreement in a gray area, exactly where disagreement is expected.
Given the design of the study, the only appropriate conclusion is that the use of wide-angle photographs leads to considerable variability in the assessment of plus disease. This study calls into question the use of the wide-angle photographs for the diagnosis of plus disease, rather than the diagnosis of plus disease per se.
If readers interpret these articles to indicate that plus disease is an unreliable feature of ROP diagnosis, then their clinical practice behavior may change in a dangerous way. Indeed, it is hard to imagine any resulting change in practice that would benefit the collective group of infants who have advanced ROP. Plus disease is difficult to diagnose clinically in borderline cases; however, when the full spectrum of plus disease is considered, there are few characteristics of ROP that have demonstrated such a strong association with the clinical sequelae of ROP. A change in practice that leaves out plus disease or causes physicians to underestimate its importance, based on this study, could place many children at increased risk of blindness.
We urge clinicians to continue to emphasize the importance of plus disease in clinical decision making. Plus disease has been extensively and clinically tested as one of the most important and alarming findings in ROP. Meanwhile, Chiang and colleagues have shown us that wide-angle photography is not useful for the diagnosis of plus disease. For this observation, we can be grateful.
Correspondence: Dr Good, Smith-Kettlewell Eye Research Institute, 2318 Fillmore St, San Francisco, CA 94115 (good@ski.org).
Financial Disclosure: None reported.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Archives of Ophthalmology editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.